Cancer Therapeutics Training (CT2) Talk | David Tyvoll, PhD and Kyle Bohnert, PhD

The Development of Pharmaceutical Inhibitors of the IRE1a/XBP1s Arm of the Unfolded Protein Response to Prevent Skeletal Muscle Loss During Cancer Cachexia

David Tyvoll, PhD is a physical chemist. He completed his undergraduate
degree at UCSD, earned his PhD at Stanford as well as
completed post-doctoral work. He also completed additional
graduate work at UCLA. He worked for Hewlett Packard and
Silverbrook Research, and most recently at the Alfred Mann
Institute for Biomedical Engineering at USC.

Kyle Bohnert, PhD completed his undergraduate degree at Hanover College,
then earned a master’s degree in Biomechanics from the
University of Kentucky, followed by a PhD in Anatomical
Sciences and Neurobiology from the University of Louisville. He
is currently an Associate Professor at St. Ambrose University in
Iowa, where he teaches Gross Anatomy and Kinesiology. His
work on cancer cachexia established the rationale for this
research effort.